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1. General Information 
Materials: 
Reagents were purchased from Sigma-Aldrich, Acros Organics or TCI-Europe. Synthetic RNA targets 
were obtained from IDT (Leuven, Belgium). The Fmoc-protected amino acids were acquired from Iris 
Biotech (Marktredwitz, Germany) and the PNA monomers from Link Technologies Ltd. (Lanarkshire, 
Scotland). HCTU and trifluoroacetic acid, N,N-diisopropylethylamine were obtained from Roth 
(Karlsruhe, Germany), DMF from VWR (Pennsylvania, USA), Oxyma from Carbolution (Saarbrücken, 
Germany). 3´-Spacer-C3-CPG (1 µmol, pore size 500 Å), 5´-thiol modifier C6 S-S CE, 3´-Palmitate-
SynBase CPG and phosphoramidites (DNA and 2´-OMe) were purchased from Link Technologies Ltd. 
(Lanarkshire, Scotland). LNA was acquired from Lexiqon (Vedbeak, Denmark) and Ribotask Aps 
(Langeskov, Denmark). DNA synthesis reagents were purchased from EMP-Biotech (Berlin, 
Germany). 
HPLC purification and analysis: 
The crude peptides and PNA were purified by using a preparative HPLC 1100 system from Agilent 
(Santa Clara, USA) and Polaris C18 A 250x21 mm, 5 µm columns from Varian (Palo Alto, USA) with a 
binary mixture of the solvents A (98.9% H2O, 1% MeCN, 0.1% TFA) and B (98.9% MeCN, 1% H2O, 
0.1% TFA) at 6 mL/min flow rate and a linear gradient. The PNA conjugates were purified using a 
LaChrome Elite system from Hitachi (Tokyo, Japan) and a Polaris 5 C18-A 250x4.6 mm column at a 
flow rate of 1 mL/min at 55°C. PNA, Peptides and conjugates were analyzed by Acquity 
ultraperformance liquid chromatography system from Waters (Eschborn, Deutscland) and a BEH130 
C18 (2.1x50mm, 1.7µm) column with a binary mixture of the solvents A (98.9% H2O, 1% MeCN, 0.1% 
TFA) and B (98.9% MeCN, 1% H2O, 0.1% TFA) at 50°C and 0.5 mL/min flow rate in a linear gradient 
shown in table 2. 
Oligonucleotides and oligonucleotide conjugates were purified by reversed-phase HPLC (DMT-on and 
-off) by using a 1105 Gilson HPLC and a YMC Triat C18 (150x10 mm, 5 µm) column at 8 mL/min flow 
rate or a YMC Triat C18 (250 x 4.6 mm, 5µm) at 1.5 mL/min flow rate and 55°C with a binary mixture 
of A (0.1 M TEAA buffer, pH = 7.5, aq.) and B (acetonitrile). Oligonucleotides and oligonucleotide 
conjugates were characterized on the YMC Triat C18 (250 x 4.6 mm, 5µm) column. 
MALDI-TOF MS: 
MALDI-TOF mass spectra were measured by using a Shimadzu Axima Confidence instrument in 
positive mode. The THPTA matrix was used (28 mg/mL 2',4',6'-trihydroxyacetophenonmonohydrate 
und 6 mg/mL citric acid diammonium salt in MeCN/H2O (1:1)).  
 
2. Synthesis 
Synthesis of PNA FIT probes and peptides 
PNA and peptides were synthesized on a Tentagel®R RAM resin from Novabiochem (Schwalbach, 
Germany) in a 10 µmol scale. For the maleimide-containing peptides, the resin was allowed to swell in 
DMF/piperidine (4:1 [v/v]) for 15 min and then washed five times with DMF. Afterwards 4 eq of Fmoc-
(Mmt)-Lys-OH, 4 eq Oxyma, 3.9 eq HCTU, 6 eq. DIPEA in DMF (0.2 M) were coupled 2 x 45 min at 
room temperature. The subsequent assembly of the peptide chain was performed by using an 
automatized peptide synthesizer from Intavis (Köln, Deutschland) and coupling Fmoc-protected amino 
acids according to manufacturer´s instructions. The removal of the Mmt-group was performed by 
treatment with 1% TFA in DCM, which was followed by a manual coupling of 6-
maleinimidohexaonicacid. To release peptides the resin was treated with TFA/TIS/thioanisole (90/4/6) 
for 1.5h. The TFA extract was concentrated using an argon stream. For precipitation, the remaining 
solution was added to ice-cold ether. The precipitate was purified by preparative HPLC. For the 
synthesis of the DTNP-peptides, cysteine was coupled as N-terminal amino acid. The peptides were 
cleaved from the resin upon treatment of TFA/TIS/H2O/EDT (95.5/2/2/0.5) for 1.5h followed by a 
precipitation in ice-cold ether. The HPLC purified material (1 eq) was modified in a reaction with 2,2'-
dithiobis(5-nitropyridine) (20 eq) in acetic acid/ water (3:1, 12 mM). After 12 h shaking the crude 
conjugate was purified by preparative HPLC. The synthesis of FIT-PNA was performed according to 
manufacturer’s instructions. For installing the N-terminal thiol function, Fmoc-6-Ahx-OH and 
subsequently 3-tritylthio-propionic acid were manually coupled. For detachment, the PNA-resin was 
treated with TFA/TIS/H2O/EDT (95.5/2/2/0.5). The TFA extract was concentrated using an argon 
stream. The remaining solution was added to ice-cold ether. The precipitate was purified by 
preparative HPLC.  
Synthesis of DNA FIT probes 
Automated DNA synthesis was performed by using a Bioautomation MerMade 4 synthesizer (Irving, 
Texas). All phosphoramidites were used according to manufacturer´s instructions. The yield of every 
coupling step was monitored by measuring the absorbance of the DMTr cleavage solution. The 
synthesis was programmed to yield the oligonucleotide carrying the DMTr protection group (“trityl-on”). 
Dyes and dye nucleotides were synthesized as described in former publications.[1] After completion of 
chain assembly the CPG was dried under vacuum. To remove the protecting groups and release the 
oligonucleotide the solid support was treated with 80% aqueous ammonia for 2.5 h at 55°C. The 
volatiles where removed under reduced pressure, the solid dissolved in water and the resulting 
solution filtered prior to HPLC purification. Afterwards, the DMTr group was removed upon treatment 
with 300 µL of 80% aqueous AcOH for 15 min at room temperature. The detritylation mixture was 
treated with 1 mL iPrOH and the resulting precipitate again purified by HPLC. 
Synthesis of DNA/PNA-Peptide Conjugates via conjugate addition to maleimide 
The Thiol-PNA was used for maleimide-ligation directly after HPLC purification. To reduce the disulfide 
protecting group DNA-based probes the oligonucleotide was dissolved (200µM) in a degassed TCEP 
buffer (5 mM TCEP, 10 mM NaCl, 10 mM NaHPO4, pH 6.5) and shaken at room temperature 
overnight. Afterwards the oligonucleotide was precipitated with 10% vol. 3 M ammonium acetate and 1 
mL isopropanol. To prevent the oxidation of the thiol the probe was dried under argon. The thiol-
oligonucleotide was dissolved (800 µM) in ligation buffer (10 mM NaCl, 10 mM NaH2PO4, pH 6.5) with 
4 eq of maleimide peptides. The mixture was stirred for 2h. Urea buffer (0.1 M KH2PO4, 0.3 M KBr, 8 
M Urea, 1 mM TCEP, pH 8) was added. The mixture was the stirred for 30 min. After filtration over a 
NAP column the conjugates were purified by HPLC. 
 
Synthesis of PNA-disulfide-CPP-conjugates 
To 1 eq. of thiol-PNA (100 µM) in buffer (1 M HEPES, 6 M Gn-HCl, pH 6.8) were added 4 eq of DTNP-
peptide. The mixture was stirred for 1h at 25°C. Subsequently, the mixture was filtrated trough a NAP 
column prior to HPLC purification. 
Table S1 Analytical data of the DNA probes. 
No. Sequence (X = Ser(TO, QB, BO)) RT/ min 
HPLC 
gradient 
MALDI-TOF-MS 
Calculated [M]+ 
/ found 
FIT-DNA1 GCCGXTLGAUUA 8.85 10% - 50% B in 10 min 
3875/ 
3873 
Pen_FIT-DNA1 
AcN-RQIKIWFQNRRMKWKKK* -S-
GCCGXTLGAUUA 21.0 
10% - 40% 
B in 33 min 
6679/ 
6672 
SAP(E)_FIT-
DNA1 
AcN-(VELPPP)3K*-S- GCCGXTLGAUUA 29.5 10% - 40% B in 30 min 
6349/ 
6341 
Palm_FIT-DNA1 C22H44N1O4P1- GCCGXTLGAUUA 17.7 30% - 70% B in 20 min 
4270/ 
4270 
FIT-DNA2 AUGCACGXCLCG 8.95 10% - 50% B in 10 min 
3868/ 
3862 
FIT-DNA3 UUUUUUUTXTLTUUUUUUU 8.80 10% - 50% B in 10 min 
5934/ 
5936 
  
Table S2 Analytical data of the PNA probes. (X = (CH2)2CO-NH(CH2)5CO) 
No. Sequence (X = Ser(TO)) RT/ min 
UPLC 
gradient 
ESI-MS 
calculated / 
found 
FIT-PNA1 HS-X-g c c g Aeg(TO) t g a t t a 1.93 3% - 60% B in 4 min 
[M]3+ 
1126.3/ 
1125.3 
Pen_FIT-PNA1 
AcN-RQIKIWFQNRRMKWKKK* -S-X- g c c g 
Aeg(TO) t g a t t a 1.94 
3% - 80% 
B in 4 min 
[M]5+ 
1197.5/ 
1197.7 
SAP(E)_FIT-
PNA1 
AcN-(VELPPP)3K*-S-X-g c c g Aeg(TO) t g a t t a 2.35 3% - 80% B in 4 min 
[M]3+ 
1131.5 / 
1131.8 
Transp_FIT-
PNA1 
AcN-LIKKALAALAKLNIKGLLYGASNLTWGC*-S-
X-g c c g Aeg(TO) t g a t t a 2.84 
3% - 80% 
B in 4 min 
[M]6+ 
1075.3/ 
1075.3 
Pep2_FIT-PNA1 
AcN-KETWFETWFTEWSQPKKKRKVC*- S-X-       
g c c g Aeg(TO) t g a t t a 2.30 
3% - 80% 
B in 4 min 
[M]6+ 
1049.1/ 
1048.9 
MPG_FIT-PNA1 
AcN-GALFLGFLGAAGSTMGAWSQPKKRKVC*- 
S-X- g c c g Aeg(TO) t g a t t a 2.58 
3% - 80% 
B in 4 min 
[M]6+ 
1055.2/ 
1054.9 
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Figure S1. RP-HPLC-UV analysis (left) and MALDI-TOF-MS analysis (right) of purified FIT probes.  
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3. Optical spectroscopy data of FIT probes 
 
 
 
 
 
Figure S2. Absorption (grey) and emission (black) of FIT-
DNA probes in absence (dotted line) and presence 
(continuous line) of complementary F-Tag RNA. 
Conditions: 0.5 µM probe und 5 eq. RNA target in PBS 
buffer (100 mM NaCl, 10 mM Na2HPO4, pH 7) at 37°C, 
TO= λex= 485 nm, λem= 535 nm, BO = λex= 440 nm, λem= 
485 nm, QB = λex= 560 nm, λem= 605 nm slitex= 5 nm, 
slitem= 5 nm. 
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Figure S3. Absorption (grey) and emission (black) of FIT-PNA probes in absence (dotted line) and presence 
(continuous line) of complementary F-Tag RNA. Conditions: 0.5 µM probe und 5 eq. RNA target in PBS buffer 
(100 mM NaCl, 10 mM Na2HPO4, pH 7) at 37°C, λex= 485 nm, λem= 535 nm, slitex= 5 nm, slitem= 5 nm. 
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4. Melting analysis of the FIT probes and FIT probe conjugates 
 
For melting analysis, the absorbance at 260 nm was monitored during a thermal cycle (3 times 20‐90 
°C in 0.5 °C/min) with 1 eq of RNA target. The probes were dissolved at 1 µM or 0.5 µM concentration 
using PBS (100 mM NaCl, 10 mM Na2HPO4, pH 7). 
 
Melting curves at 1 µM concentration 
 
Figure S4. Normalized melting curve (black) and derivation (grey). Conditions: 1 µM probe and 1 eq. RNA target 
in PBS (100 mM NaCl, 10 mM Na2HPO4, pH 7) 20-90 °C. λem= 260 nm. 
 
Melting curves of 0.5 µM DNA FIT-Probes and DNA FIT-Probe conjugates  
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Figure S5. Melting curve (black) and derivation (grey). Conditions: 0.5 µM probe and 1 eq. RNA target in PBS 
buffer (100 mM NaCl, 10 mM Na2HPO4, pH 7) 20-90 °C. λem= 260 nm. 
 
Melting curves of 0.5 µM PNA FIT-Probes and PNA FIT-Probe conjugates 
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Figure S6. Melting curve (black) and derivation (grey). Conditions: 0.5 µM probe und 1 eq. RNA target in PBS 
buffer  (100 mM NaCl, 10 mM Na2HPO4, pH 7) 20-90 °C. λem= 260 nm.  
 
5. Permanent transfection of Flp-InTM 293 T-Rex cellsTM with F-tagged mCherry 
To express a repeat sequence of mRNA together with an mCherry open reading frame under control 
of an inducible promoter, we employed oligo condensation and MultiSite-GatewayTM recombination 
cloning from Invitrogen (Carlsbad, USA). First, we designed a synthetic 22 nt long RNA sequence. 
Unique sequence identity was verified by BLAST search in the human genome. We then synthesized 
complementary oligonucleotides (5’ 
GATCCTAATCAACGGCCGGACGTGCATCTAATCAACGGCCGGACGTGCATA 3’) containing two 
repeats of this binding sequence, phosphorylated them with polynucleotide kinase and hybridized 
them to form double stranded oligonucleotides with overhangs compatible with BamHI and BglII 
restriction sites. We polymerized these oligonucleotides in the presence of both restriction enzymes 
using T4 ligase, purified products of 300-500 bp length by agarose gel electrophoresis and cloned 
them into a custom gateway donor vector containing a stop codon in front of a multiple cloning site. 
This resulted in a product with 9 repeats of the binding sequence in head-to-tail orientation, which was 
validated by sequencing. We repeatedly re-inserted this fragment using a terminal BamHI restriction 
site as well a BglII/XmaI sites to finally obtain a vector with 45 repeats of the binding sequence. To 
generate an expression plasmid we used previously generated donor vectors containing the mCherry 
ORF, as well as a CMV promoter followed by Tet-operators (CMV-TO).  We then generated a fusion 
construct by three-fragment recombination (LR Clonase Plus) from Invitrogen (Carlsbad, USA) using 
all three donor plasmids and a custom destination vector containing R4 and R3 recombination sites for 
the Multiside-Gateway system as well as an FRT site for Flp-InTM recombination. Stable cell lines were 
generated using Flp-InTM 293 T-Rex cellsTM by co-transfection of a plasmid expressing Flp 
recombinase and the reporter plasmid as described previously by Spitzer et al (Methods in 
Enzymology, Vol 529 99-124, 2013). Hek 293 T-Rex cells were maintained at 37°C and 5% CO2 in 
DMEM supplemented with 10% fetal calf serum, 100 U/mL penicillin, 100 µg/mL streptomycin, 100 
µg/mL Zeocine to select for the FRT recipient site and 15 µg/mL Blasticidine to select for Tet-R gene 
expression. 24h after transfection cells were selected for integration of the reporter plasmid using 100 
µg/mL Hygromycin B until distinct colonies had formed. Individual clones were isolated, cultured and 
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validated in time course experiments. Inducible F-RNA expression was measured by quantitative real-
time PCR using primers specific for the mCherry ORF. Protein translation from induced F-RNA was 
validated by Western Blot as well as time-lapse microscopy imaging of mCherry fluorescent protein. 
  
Figure S8. Plasmid map used for transfection of the Flp-InTM 293 T-Rex cellsTM 
 
6. PCR (Polymerase Chain Reaction) of mcherry mRNA 
Permanently transfected Flp-InTM 293 T-Rex cellsTM were trypsinated after different times of 
doxycycline incubation (15 min, 30 min, 45 min and 60 min) in phenol red free DMEM. For purification 
of total RNA, the RNeasy Mini Kit (Qiagen) was used following the manufacturer's instructions. Total 
RNA was eluted in 30 μL RNase free H2O. RNA concentration was determined by an optical density 
(OD) measurement. For in vitro cDNA synthesis a High Capacity cDNA reverse Transcription Kit from 
Applied Biosystems and a TGradient from Biometra was used. Real-time PCR was performed in a 
Figure S7. 51 nt long sequence oft he synthesized oligonucleotides for the repeat sequence. 
volume of 20 µL in 96-wellplates by using an iQ-Thermocycler (BioRad). Specific primers (forward: 5´-
cagctttcttgtacaaagtggca-3´; reverse: 5´-attaggatcccccgggctg-3´) for the amplification of a 139-bp 
sequence between the mCherry and the F-tag region (Seq1) were selected with Primer-BLAST 
(www.ncbi.nlm.nih.gov/tools/primer-blast/). Primers and synthetic templates were purchased from 
Biomers (Ulm, Germany). As negative control (No Template Control, NTC) the cDNA was replaced by 
RNase free water. All measurements were performed in triplicates. The mastermix for 20 µL consisted 
of 9.8 µL H2O, 2.0 µL 10 x reaction buffer S, 4.0 µL 5x enhancer solution P (both VWR, #01-8120), 1.0 
µL 25mM MgCl2, 0.4 µL dNTP´s (mix, 10 mM each), 0.8 µL of each primer (10 µM), 1.0 µL SYBRGold 
(10x), 1.0 µL cDNA solution (10ng/µL), 1unit HotStart Taq polymerase from VWR (#01-8120). The 
solutions were transferred into 96-wellplates and cDNA was amplified under the following cycle-
conditions: initial denaturation at 95°C for 4 min followed by 30 to 40 cycles of denaturation (95°C, 10 
sec), annealing (59°C, 20 sec) and elongation (72°C, 20sec).  
For quantification a calibration curve was generated with different concentrations (0.1 – 10-6 ng/µl) of a 
synthetic 139-bp DNA template (5´-CAGCTTTCTTGTACAAAGTGGCATAATGATGAATTG 
TAATACGACTCACTATAGGGCGAATTGGGTACCGGGCCCCCCCTCGAGGTCGACGGTATCGATA
AGCTTGATATCGAATTCCTGCAGCCCGGGGGATCC-3´) analogous to the PCR product Seq1 from 
cDNA. The cycle of threshold (Ct) values correspond to a certain number of copies in 1 µL of the 
starting material (Fig. S9).  
 
 
 
 
 
Figure S9. Logarithmic presentation of the 
calibration curve after amplification of a 
139-bp DNA target encoding for Seq1, a 
sequence between the mCherry and the 
F-tag region in a 10-fold dilution series 
(0.1 – 10-6 ng/µL). The equation describes 
the correlation between the Ct value and 
the number of copies in 1 µl starting 
material. 
 
The equation shown in Fig. S9 allows the conversion of any Ct value determined by PCR of cDNA into 
a copy number of Seq1 per ng starting material (copies/ng = 10 exp. (Ct value – 39.855) / -3,4918). 
Considering the number of counted cells per sample we calculated the number of target copies per 
cell (Table S3, Fig. S10). 
 
y = -3,4918x + 39,855
R² = 0,9982
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 Figure S10. Amplification curves for quantitative PCR analysis of mRNA extract obtained after different 
incubation times of Flp-InTM 293 T-Rex cellsTM with 2 µg / mL doxycycline (SYBRGold as fluorescence marker). 
The curves represent the means of three experiments with 3 replicates each. 
 
Table S3: Ct values (mean of at least three experiments with 3 replicates each) and calculated numbers of Seq1 
copies per Flp-InTM 293 T-Rex cellTM after different times of incubation with doxycyclin.  
 
Sample-
Nr. 
Incubation 
time (min) Ct value  
Copies / ng 
starting 
material 
starting 
material 
/ sample 
(ng) 
copies / 
sample 
cells / 
sample 
copies / 
cell 
1 
0 20.4  38628  1140 4.404E+07 200000 220 
15 20.8  28383  2130 6.046E+07 200000 302 
30 19.8  57187  1260 7.206E+07 200000 360 
45 20.2  41855  1500 6.278E+07 200000 314 
60 19.1  85788  1860 1.596E+08 200000 798 
2 
0 24.0  3382  1170 3.957E+06 120000 33 
15 20.9  66459  240 1.595E+07 120000 133 
30 18.9  254022  240 6.097E+07 120000 508 
45 18.3  163689  540 8.839E+07 120000 737 
60 20.0  49628  870 4.318E+07 120000 360 
3 
0 23.1  6398  600 3.839E+06 75000 51 
15 22.8  14059  330 4.639E+06 75000 62 
30 24.0  3275  630 2.063E+06 75000 28 
45 19.9  50508  1020 5.152E+07 75000 687 
60 17.7  166606  810 1.350E+08 75000 1799 
4 60 18.3 18578 4681 8.695E+07 140000 621 
5 60 16.8 12891 5640 2.467E+08 140000 670 
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 7. Live cell imaging 
 
Figure S12. Zoomed in fluorescence microscopy 
images of living HEK293 cells after 30 min incubation 
with 1 µM Pen_FIT-PNA1 in PBS at 37 °C and 5% CO2. 
The left image and the right image show cells without (-
dox) and with (+dox) induction of F-tagged mCherry 
mRNA. Green colour shows the signal from TO 
emission with 500/24 nm filter ; -dox, +dox = without 
and with addition of doxycycline (2 µg/ mL) 1 h before 
incubation with probes. Scale bar is 20 µm. Blue colour 
shows the signals from nucleus. 
 
 
 
Complexation of FIT-DNA1 with octaarginine 
FIT-DNA1 (12 pmol) and different amounts of octaarginine were mixed in PBS and filled into the gel 
pockets (10 µL) of a 1% agarose gel. The electrophoresis was performed for 20 min at 100 V in 1 x 
TAE buffer using a PowerPac HC from Bio-Rad. Afterwards the FIT probe was stained for 5 min with 
SYBRGold™ and fluorescence imaged by using a Kodak Image Station 4000 MM Pro (λex= 495 nm 
and λem= 535 nm). The lack of DNA staining by SYBRGold™ was taken as an indicator for quantitative 
DNA complexation, which appeared complete when at a positive/negative charge ratio P/N=16. 
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Figure S11. Average copy number of the Seq1 template per cell after different 
incubation periods with 2 µg/mL doxycycline. Mean of three independent 
experiments (Table S3) is shown with SD. 
 Figure S13.  1%-agarose gel analysis of SYBRGold™-stained mixtures of FIT-DNA1 and octaarginine at various 
positive/negative charge ratios P/N. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure S14. Magnified merged bright field and fluorescence microscopy images of permanently transfected Flp-
InTM 293 T-RExTM cells without (-dox) and with (+dox) induction of F-tag-mCherry mRNA expression after 
incubation with DNA (2 µM) or PNA FIT probes (1 µM) for 30 min in PBS at 37 °C and 5% CO2. -dox, +dox = 
without and with addition of doxycycline (2 µg/ mL) 1 h before incubation with probes. Filter sets: TO ex = 500/24 
nm, TO em = 545/40 nm.  
 
 
 
Transfection over night 
The cells were incubated over night with probe (1 µM FIT-DNA1 or 250 nM FIT-PNA2) in antibiotic 
free DMEM at 37°C and 5 % CO2. 2 µg/ mL doxycycline was added and after 1 h the cells were 
washed twice with DPBS + 1 mM MgCl2, and imaged in DPBS or for longer time in phenol red free 
DMEM. 
 
 
 
 
 
 
 
 
 
 Figure S15. Bright field and fluorescence microscopy images of permanently transfected Flp-InTM 293 T-RExTM 
cells without (-dox) and with (+dox) induction of F-tag-mCherry mRNA expression over night after incubation with 
FIT DNA probes (1 µM) or FITPNA probes (250 nM). green = TO emission of FIT probes. Filter sets: TO ex = 
500/24 nm, TO em = 545/40 nm. Scale bar is 20 µm. 
 
 
 
Image analysis of the fluorescence images using ROI (Region Of Interest) 
 
Figure S16. Representative analysis of the fluorescence microscopy images of permanently transfected HEK293 
cells without (- dox) and with (+dox) induction of F-tagged mCherry mRNA obtained after SLO-mediated delivery 
of 2 µM FIT-DNA1. Cells showing high fluorescence intensity and healthy shape were surrounded by using the 
ROI tool of the Olympus IX83 software. Afterwards the mean intensity value of 50 cells was calculated.  
 
  
 Figure S17. Mean fluorescence of Flp-InTM 293 T-RExTM cells after SLO induced delivery of FIT-DNA1, FIT-PNA1 
and FIT-DNA2 without (– dox) and with (+dox) induction of F-tagged mCherry mRNA. The Box-Whisker plots (1.5 
IQR) show the signal intensity of experiments with three different cell cultures. Fluorescence intensity was 
measured by image analysis (see Fig. S16). The number N of cells analysed is given in brackets. Conditions: 2 
µg/ mL doxycycline (if added); after 1 h cells are permeabilized with 150 U/mL SLO for 10 min in PBS + 1mM 
MgCl2 at 37°C and 5% CO2 in presence of FIT probes. Filter sets: TO ex = 500/24 nm, TO em = 545/40 nm; QB 
ex = 575/25, QB em = 628/40 nm. 
 
Cell Viability  
Cells treated with probes or SLO were washed twice with DPBS + 2 mM MgCl2 and then incubated 
with propidiumiodid in PBS (1µg/mL) purchased from Thermo Fisher Scientific (Rockford, USA) for 5 
min followed by Hoechst 33342 staining (5 µg/mL) for 5 min. Afterwards cells with a propidiumiodid 
stain (dead cells) were counted and divided though all cells counted by the nucelus stain. 100-180 
cells were included per measurement. 
  
Figure S18. Bar chart of the cell death in % after different transfection treatments.  
 
 
 
[1] I. G. Felix Hövelmann, Jasmine Chamiolo, Marc Kasper, Jonas Steffen, Anne Ephrussi, Oliver 
Seitz, Chemical Science 2016, 7, 128--135. 
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